Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Boyer

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
JPEN. Journal of Parenteral and Enteral Nutrition|November 1, 1986
Plasma phospholipid fatty acids and urinary excretion of prostaglandins PGE1 and PGE2 in infants during total parenteral nutrition, with continuous or sequential administration of fat emulsionJ Ghisolfi, J Garcia, J P Thouvenot, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 8, 1998
The use of unproven methods of treatment by cancer patients. Frequency, expectations and costM Miller, M J Boyer, P N Butow, et al.
The Medical Journal of Australia|June 28, 2000
Evaluation of the role of positron emission tomography in oncologyR C Viney, M J Fulham, B C McCaughan, et al.
Journal of Neurochemistry|February 1, 1990
mu-Opioid receptors and not kappa-opioid receptors are coupled to the adenylate cyclase in the cerebellumJ Polastron, M J Boyer, Y Quertermont, et al.
Internal Medicine Journal|September 24, 2005
Weekly docetaxel as second line treatment after mitozantrone for androgen-independent prostate cancerA M Joshua, I Nordman, R Venkataswaran, et al.
Archives of Internal Medicine|March 22, 1993
Ectopic corticotropin syndrome and small-cell carcinoma of the lung. Clinical features, outcome, and complicationsL Delisle, M J Boyer, D Warr, et al.
Cancer Chemotherapy and Pharmacology|January 19, 2010
A phase II study of fenretinide in patients with hormone refractory prostate cancer: a trial of the Cancer Therapeutics Research GroupM M Moore, M Stockler, R Lim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2002
Phase II trial of pemetrexed disodium (ALIMTA, LY231514) in chemotherapy-naïve patients with advanced non-small-cell lung cancerS J Clarke, R Abratt, L Goedhals, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1997
Phase I study of paclitaxel and oral etoposide in previously untreated non-small-cell and extensive small-cell lung cancerM J Boyer, J Zalcberg, I N Olver, et al.
Annales De Biologie Clinique|October 13, 1999
[Multicenter evaluation on different analyzers of three methods for direct HDL-cholesterol assay]M Egloff, D Léglise, L Duvillard, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
JPEN. Journal of Parenteral and Enteral Nutrition|November 1, 1986
Plasma phospholipid fatty acids and urinary excretion of prostaglandins PGE1 and PGE2 in infants during total parenteral nutrition, with continuous or sequential administration of fat emulsionJ Ghisolfi, J Garcia, J P Thouvenot, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 8, 1998
The use of unproven methods of treatment by cancer patients. Frequency, expectations and costM Miller, M J Boyer, P N Butow, et al.
The Medical Journal of Australia|June 28, 2000
Evaluation of the role of positron emission tomography in oncologyR C Viney, M J Fulham, B C McCaughan, et al.
Journal of Neurochemistry|February 1, 1990
mu-Opioid receptors and not kappa-opioid receptors are coupled to the adenylate cyclase in the cerebellumJ Polastron, M J Boyer, Y Quertermont, et al.
Internal Medicine Journal|September 24, 2005
Weekly docetaxel as second line treatment after mitozantrone for androgen-independent prostate cancerA M Joshua, I Nordman, R Venkataswaran, et al.
Archives of Internal Medicine|March 22, 1993
Ectopic corticotropin syndrome and small-cell carcinoma of the lung. Clinical features, outcome, and complicationsL Delisle, M J Boyer, D Warr, et al.
Cancer Chemotherapy and Pharmacology|January 19, 2010
A phase II study of fenretinide in patients with hormone refractory prostate cancer: a trial of the Cancer Therapeutics Research GroupM M Moore, M Stockler, R Lim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2002
Phase II trial of pemetrexed disodium (ALIMTA, LY231514) in chemotherapy-naïve patients with advanced non-small-cell lung cancerS J Clarke, R Abratt, L Goedhals, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1997
Phase I study of paclitaxel and oral etoposide in previously untreated non-small-cell and extensive small-cell lung cancerM J Boyer, J Zalcberg, I N Olver, et al.
Annales De Biologie Clinique|October 13, 1999
[Multicenter evaluation on different analyzers of three methods for direct HDL-cholesterol assay]M Egloff, D Léglise, L Duvillard, et al.
Pageof 6